<bill session="104" type="h" number="1566" updated="2013-07-14T18:47:34-04:00">
  <state datetime="1995-05-03">REFERRED</state>
  <status>
    <introduced datetime="1995-05-03"/>
  </status>
  <introduced datetime="1995-05-03"/>
  <titles>
    <title as="introduced" type="official">To amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions and to provide for carryovers and carrybacks of unused credits.</title>
  </titles>
  <sponsor id="400205"/>
  <cosponsors>
    <cosponsor id="400119" joined="1995-07-13"/>
    <cosponsor id="400140" joined="1995-07-13"/>
    <cosponsor id="407226" joined="1995-06-07"/>
    <cosponsor id="400256" joined="1995-05-03"/>
    <cosponsor id="400291" joined="1995-05-15"/>
    <cosponsor id="400308" joined="1995-06-07"/>
    <cosponsor id="400366" joined="1995-07-13"/>
    <cosponsor id="400380" joined="1995-07-21"/>
  </cosponsors>
  <actions>
    <action datetime="1995-05-03">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E939"/>
    </action>
    <action state="REFERRED" datetime="1995-05-03">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="104" type="s" number="1052"/>
  </relatedbills>
  <subjects>
    <term name="Income tax"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Diseases"/>
    <term name="Drug industry"/>
    <term name="Health"/>
    <term name="Orphan drugs"/>
    <term name="Pharmaceutical research"/>
    <term name="Science, technology, communications"/>
    <term name="Tax credits"/>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary>5/3/1995--Introduced.
Amends the Internal Revenue Code to extend permanently the tax credit for expenses of clinical testing of certain drugs for rare diseases or conditions. Allows a three-year carryback and 15-year carryforward of unused credit amounts, except that no credit may be carried to a taxable year beginning before January 1, 1995.</summary>
</bill>
